Smart Dalton E. III 4

What Happened
Dalton E. Smart III, Senior Vice President — Finance & Global Controller at Merck (MRK), exercised stock options to acquire 4,000 shares (exercise price $62.07, cost $248,280) and sold a total of 6,400 shares in open-market transactions on Feb 4, 2026 at $119.67 per share for combined proceeds of $765,920. The transactions result in gross proceeds considerably above the exercise cost (sale proceeds minus exercise cost ≈ $517,640), consistent with a cashless/near-immediate sale following option exercise.

Key Details

• Transaction date: February 4, 2026; Form 4 filed February 6, 2026 (timely — within the 2‑business‑day reporting window).
• Option exercise: 4,000 shares acquired at $62.07 each (total $248,280).
• Open-market sales: 4,000 shares sold at $119.67 (reported $478,700) and 2,400 shares sold at $119.67 (reported $287,220); total proceeds $765,920.
• Derivative entry: a derivative disposal of 4,000 shares at $0.00 is reported (related to the option exercise mechanics).
• Shares owned after the transactions: not specified in the provided filing details.
• Footnote: the option exercised vested in equal installments on 5/5/2018, 5/5/2019 and 5/5/2020.

Context

• This sequence (exercise of options followed by immediate sale of shares) is commonly a cashless exercise—the insider exercises options and sells shares right away, often to cover the exercise cost and taxes.
• Sales by executives are routine and do not, by themselves, indicate company outlook; purchases are generally viewed as a stronger signal of insider confidence.
• No 10b5-1 plan, tax-withholding mechanics, or late-filing flags were disclosed in the provided details.